U.S. flag

An official website of the United States government

NM_001737.5(C9):c.256C>T (p.Arg86Ter) AND not provided

Germline classification:
Pathogenic (1 submission)
Last evaluated:
Dec 23, 2023
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV002914964.2

Allele description [Variation Report for NM_001737.5(C9):c.256C>T (p.Arg86Ter)]

NM_001737.5(C9):c.256C>T (p.Arg86Ter)

Gene:
C9:complement C9 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
5p13.1
Genomic location:
Preferred name:
NM_001737.5(C9):c.256C>T (p.Arg86Ter)
HGVS:
  • NC_000005.10:g.39341628G>A
  • NG_009894.1:g.27926C>T
  • NM_001737.5:c.256C>TMANE SELECT
  • NP_001728.1:p.Arg86Ter
  • NP_001728.1:p.Arg86Ter
  • LRG_32t1:c.256C>T
  • LRG_32:g.27926C>T
  • LRG_32p1:p.Arg86Ter
  • NC_000005.9:g.39341730G>A
  • NM_001737.3:c.256C>T
Protein change:
R86*
Molecular consequence:
  • NM_001737.5:c.256C>T - nonsense - [Sequence Ontology: SO:0001587]

Condition(s)

Synonyms:
none provided
Identifiers:
MedGen: C3661900

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV003267626Invitae
criteria provided, single submitter

(Invitae Variant Classification Sherloc (09022015))
Pathogenic
(Dec 23, 2023)
germlineclinical testing

PubMed (3)
[See all records that cite these PMIDs]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

The human complement C9 gene: identification of two mutations causing deficiency and revision of the gene structure.

Witzel-Schlömp K, Späth PJ, Hobart MJ, Fernie BA, Rittner C, Kaufmann T, Schneider PM.

J Immunol. 1997 May 15;158(10):5043-9.

PubMed [citation]
PMID:
9144525

A non-sense mutation at Arg95 is predominant in complement 9 deficiency in Japanese.

Horiuchi T, Nishizaka H, Kojima T, Sawabe T, Niho Y, Schneider PM, Inaba S, Sakai K, Hayashi K, Hashimura C, Fukumori Y.

J Immunol. 1998 Feb 1;160(3):1509-13.

PubMed [citation]
PMID:
9570574
See all PubMed Citations (3)

Details of each submission

From Invitae, SCV003267626.2

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (3)

Description

This sequence change creates a premature translational stop signal (p.Arg86*) in the C9 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in C9 are known to be pathogenic (PMID: 9144525, 9570574). This variant is present in population databases (rs148881448, gnomAD 0.2%). This variant has not been reported in the literature in individuals affected with C9-related conditions. ClinVar contains an entry for this variant (Variation ID: 2057844). For these reasons, this variant has been classified as Pathogenic.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Feb 20, 2024